Details of the Drug Combinations

General Information of This Drug (ID: DMWLQV8)

Drug Name

NV-07a DMWLQV8

Synonyms

NV-07; NV-07alpha; NV-07beta; Phenolic hormones (anti-inflammatory), Novogen

Indication

Disease Entry	ICD 11	Status	REF
Inflammatory bowel disease	DD72	Investigative	[1]
------------------------------------------------------------------------------------

List of Combinatorial Drugs (CBD) Containing This Drug

1 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Thalidomide + NV-07a	DC8AFVH	Thalidomide	Coronavirus Disease 2019 (COVID-19)	[2]
------------------------------------------------------------------------------------

References

1	UV radiation-induced immunosuppression is greater in men and prevented by topical nicotinamide. J Invest Dermatol. 2008 Feb;128(2):447-54.
2	ClinicalTrials.gov (NCT04273581) The Efficacy and Safety of Thalidomide Combined With Low-dose Hormones in the Treatment of Severe COVID-19. U.S. National Institutes of Health.